Nektar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Go back to Nektar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 71.04 +6.65 (10.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.39 | 52 Week High | $19.98 | |||
| Open | $65.03 | 52 Week Low | $10.52 | |||
| Day High | $71.20 | P/E | N/A | |||
| Day Low | $64.97 | EPS | $-1.45 | |||
| Volume | 1,120,628 | |||||
